BG-C9074
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-C9074, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors [Phase 1]